Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announces it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent’s innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acquisition adds $1 billion to the total addressable market of the Company’s offerings, while providing unique market opportunities for access to the attractive ENT device segment.
Read the full article: Integra LifeSciences Completes the Acquisition of Acclarent, Inc. //
Source: https://www.globenewswire.com/news-release/2024/04/01/2855464/1063/en/Integra-LifeSciences-Completes-the-Acquisition-of-Acclarent-Inc.html